Therapeutic dendrimers
US10888624B2 · kind B2 · utility
1Cited by
9References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2019 |
| Grant date | Jan 12, 2021 |
| Priority date | — |
| Expiry date | Apr 5, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G83/003
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are dendrimers of formula (I): and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions comprising the dendrimer of formula (I) and methods of using the same for treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.